Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy
Abstract Purpose Cisplatin is a critical component of first‐line chemotherapy for several cancers, but causes peripheral sensory neuropathy, hearing loss, and tinnitus. We aimed to identify comorbidities for cisplatin‐induced neurotoxicities among large numbers of similarly treated patients without...
Κύριοι συγγραφείς: | Xindi Zhang, Matthew R. Trendowski, Emma Wilkinson, Mohammad Shahbazi, Paul C. Dinh, Megan M. Shuey, Regeneron Genetics Center, Darren R. Feldman, Robert J. Hamilton, David J. Vaughn, Chunkit Fung, Christian Kollmannsberger, Robert Huddart, Neil E. Martin, Victoria A. Sanchez, Robert D. Frisina, Lawrence H. Einhorn, Nancy J. Cox, Lois B. Travis, M. Eileen Dolan |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
Wiley
2022-07-01
|
Σειρά: | Cancer Medicine |
Θέματα: | |
Διαθέσιμο Online: | https://doi.org/10.1002/cam4.4644 |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Comprehensive association analysis of speech recognition thresholds after cisplatin‐based chemotherapy in survivors of adult‐onset cancer
ανά: Mohammad Shahbazi, κ.ά.
Έκδοση: (2023-02-01) -
Association of hearing loss and tinnitus symptoms with health‐related quality of life among long‐term oropharyngeal cancer survivors
ανά: Puja Aggarwal, κ.ά.
Έκδοση: (2023-01-01) -
Development of Tinnitus and Hyperacusis in a Mouse Model of Tobramycin Cochleotoxicity
ανά: Ryan J. Longenecker, κ.ά.
Έκδοση: (2021-09-01) -
Comparison of GWAS results between de novo tinnitus and cancer treatment-related tinnitus suggests distinctive roles for genetic risk factors
ανά: Mohammad Shahbazi, κ.ά.
Έκδοση: (2024-11-01) -
Topical gentamicin-induced acute vestibulopathy: A case report
ανά: Teik Beng Lau, κ.ά.
Έκδοση: (2023-05-01)